Platform
Features
Pricing
NextPhase Therapeutics
Contact
Erik D. Laursen has more than twenty years of drug development experience in pharma and biotechnology companies in the U.S. and Europe.
This person is not in the org chart
9 members
ReCode Therapeutics
Eleven Therapeutics
Aiforia
Hycor Biomedical LLC
Ventana Medical Systems